BLOG

Friday, September 3, 2021

RIL arm buys majority stake in Strand Life Sciences for Rs 393 crore

RIL is expected to further invest up to Rs 160 crore in the genomic testing firm by March, 2023

from Companies https://ift.tt/3h3eYUa
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...